(CPRX) Catalyst - Performance 61.4% in 12m
Compare CPRX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
90.45%
#3 in Group
Rel. Strength
92.07%
#634 in Universe
Total Return 12m
61.40%
#24 in Group
Total Return 5y
389.72%
#5 in Group
P/E 17.9
57th Percentile in Group
P/E Forward 13.4
50th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 10.2%
100th Percentile in Group
12m Total Return: CPRX (61.4%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: CPRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CPRX
Total Return (including Dividends) | CPRX | XBI | S&P 500 |
---|---|---|---|
1 Month | 0.16% | 2.28% | -0.87% |
3 Months | 7.67% | -10.48% | -7.58% |
12 Months | 61.40% | -1.83% | 11.88% |
5 Years | 389.72% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | CPRX | XBI | S&P 500 |
1 Month | 18.3% | 56.6% | 23% |
3 Months | 22.9% | -89.3% | -88.5% |
12 Months | 89.2% | -42.4% | 55.1% |
5 Years | 93.0% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #112 | -2.07% | 1.04% |
3 Month | #31 | 20.3% | 16.5% |
12 Month | #25 | 64.4% | 44.3% |
5 Years | #4 | 461% | 133% |
FAQs
Does CPRX Catalyst outperforms the market?
Yes,
over the last 12 months CPRX made 61.40%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months CPRX made 7.67%, while XBI made -10.48%.
Over the last 3 months CPRX made 7.67%, while XBI made -10.48%.
Performance Comparison CPRX vs Indeces and Sectors
CPRX vs. Indices CPRX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.49% | 1.03% | 13.3% | 49.5% |
US NASDAQ 100 | QQQ | 0.46% | -1.24% | 12.9% | 48.7% |
US Dow Jones Industrial 30 | DIA | 2.43% | 3.34% | 13.4% | 52.2% |
German DAX 40 | DAX | 2.72% | -1.16% | -6.24% | 36.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.45% | 2.98% | 16.3% | 55.4% |
Hongkong Hang Seng | HSI | 2.48% | 0.10% | 11.4% | 47.5% |
India NIFTY 50 | INDA | 4.33% | -3.90% | 13.0% | 58.3% |
Brasil Bovespa | EWZ | 2.29% | -4.44% | 9.58% | 67.2% |
CPRX vs. Sectors CPRX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 1.24% | 1.21% | 7.15% | 37.4% |
Consumer Discretionary | XLY | 1.41% | 0.26% | 10.8% | 48.1% |
Consumer Staples | XLP | 4.99% | -0.04% | 7.97% | 50.2% |
Energy | XLE | 5.97% | 14.0% | 19.1% | 72.5% |
Financial | XLF | 2.88% | 2.27% | 5.68% | 38.7% |
Health Care | XLV | 1.57% | 3.95% | 15.0% | 59.7% |
Industrial | XLI | 1.07% | 0.05% | 12.6% | 51.8% |
Materials | XLB | 2.10% | 2.59% | 20.7% | 64.9% |
Real Estate | XLRE | 3.01% | 1.47% | 14.2% | 43.3% |
Technology | XLK | -0.96% | -1.53% | 16.6% | 53.7% |
Utilities | XLU | 4.33% | 0.10% | 11.2% | 39.6% |
Aerospace & Defense | XAR | 0.54% | -6.23% | -0.25% | 34.8% |
Biotech | XBI | 0.19% | -2.12% | 25.9% | 63.2% |
Homebuilder | XHB | 2.18% | 2.43% | 28.1% | 68.4% |
Retail | XRT | 3.06% | 0.72% | 18.9% | 64.1% |